Divozilimab (Anti-CD20)
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.
Trivial name | BCD-132 |
Catalog Number | A2823 |
CAS# | 2254061-60-2 |
Size | 1mg*5 |